SubsidieMeestersA NON-INVASIVE, ADAPTIVE DIGITAL THERAPEUTIC SOLUTION FOR POST-TRAUMATIC STRESS DISORDER AND OTHER MENTAL DISORDERS
GrayMatters aims to treat PTSD using a non-invasive, machine-learning-based EEG-Neurofeedback device to help patients control amygdala activity, showing promising clinical results.
Projectdetails
Introduction
Post-traumatic stress disorder (PTSD) is a severe mental disorder, annually affecting 3.2% of the population, with a global market size estimated at €7.5B. Current treatments’ success is marginal, costly, and often accompanied by severe side effects.
Innovation
GrayMatters is the first to introduce a non-invasive digital therapeutics device that harnesses brain plasticity to help PTSD patients control abnormal brain-region activity. Our patented innovation uses machine learning to convert EEG signals into an fMRI-like signal of the amygdala. This allows patients to learn to self-control their amygdala activity level using an affordable EEG-Neurofeedback device.
Clinical Trials
Initial clinical trials on stress resilience and PTSD patients showed significant positive clinical results.
Team Experience
The founders have over 25 years of experience in commercialization, healthcare, and technology, with several successful startup exits and IPOs.
Partnerships
Letters of Intent (LOIs) include top mental institutes and world-renowned Key Opinion Leaders (KOLs) in PTSD psychiatry.
Recognition
GrayMatters was recently chosen as one of 8 innovative companies by Nature magazine.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 3.594.250 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 31-5-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- GRAYMATTERS HEALTH LTDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development of a novel class of therapeutics for PTSD treatment and other neurodegenerative disordersReST Therapeutics aims to develop FENM, a novel NMDA receptor-targeting therapy for PTSD and Alzheimer's, with plans for clinical trials and expanding its drug pipeline by 2027. | EIC Accelerator | € 2.491.062 | 2024 | Details |
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitationCorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Science-based Brain Training at the comfort of your home – medically certifiedBrainhero offers a cost-effective, portable EEG neurofeedback solution for home therapy, enhancing personalized treatment for children with ASD and ADHD while reducing setup time and therapy costs. | EIC Accelerator | € 2.479.700 | 2023 | Details |
Development and commercialisation of a next generation sports head guard, embedded with clinically validated sensors, for the detection of sports induced brain injuries.Contego Sports is developing NProSend, a clinically approved headgear that reduces linear impacts by 75% and rotational impacts by 55%, while also enabling early detection of concussions through IoT and AI. | EIC Accelerator | € 2.318.032 | 2022 | Details |
Development of a novel class of therapeutics for PTSD treatment and other neurodegenerative disorders
ReST Therapeutics aims to develop FENM, a novel NMDA receptor-targeting therapy for PTSD and Alzheimer's, with plans for clinical trials and expanding its drug pipeline by 2027.
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation
CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.
Science-based Brain Training at the comfort of your home – medically certified
Brainhero offers a cost-effective, portable EEG neurofeedback solution for home therapy, enhancing personalized treatment for children with ASD and ADHD while reducing setup time and therapy costs.
Development and commercialisation of a next generation sports head guard, embedded with clinically validated sensors, for the detection of sports induced brain injuries.
Contego Sports is developing NProSend, a clinically approved headgear that reduces linear impacts by 75% and rotational impacts by 55%, while also enabling early detection of concussions through IoT and AI.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
60-Hz light entrainment to unlock mental health conditionsThis project aims to develop a non-invasive light-based therapy to enhance cognitive function by targeting the perineuronal net in mice, with potential applications for anxiety and PTSD treatment. | ERC Proof of... | € 150.000 | 2024 | Details |
AlphaBeatsAlphaBeats ontwikkelt een digitale meditatie-oplossing met biofeedback om stress te verminderen via persoonlijke muziek en real-time data-analyse. | Mkb-innovati... | € 20.000 | 2021 | Details |
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental HealthThis project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders. | ERC Consolid... | € 1.999.875 | 2025 | Details |
Adaptieve behandeling van angststoornissenOntwikkeling van een innovatief platform dat VR en biofeedback integreert voor gepersonaliseerde behandeling van angststoornissen, met als doel kostenbesparing en effectiviteit in de geestelijke gezondheidszorg. | Mkb-innovati... | € 172.773 | 2017 | Details |
Transient inactivation of hypothalamic hormone release to prevent post-traumatic stress sensitizationThe project aims to develop small-molecule inhibitors targeting stress-related neurocircuits to create a novel pharmacotherapy for PTSD. | ERC Proof of... | € 150.000 | 2022 | Details |
60-Hz light entrainment to unlock mental health conditions
This project aims to develop a non-invasive light-based therapy to enhance cognitive function by targeting the perineuronal net in mice, with potential applications for anxiety and PTSD treatment.
AlphaBeats
AlphaBeats ontwikkelt een digitale meditatie-oplossing met biofeedback om stress te verminderen via persoonlijke muziek en real-time data-analyse.
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health
This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.
Adaptieve behandeling van angststoornissen
Ontwikkeling van een innovatief platform dat VR en biofeedback integreert voor gepersonaliseerde behandeling van angststoornissen, met als doel kostenbesparing en effectiviteit in de geestelijke gezondheidszorg.
Transient inactivation of hypothalamic hormone release to prevent post-traumatic stress sensitization
The project aims to develop small-molecule inhibitors targeting stress-related neurocircuits to create a novel pharmacotherapy for PTSD.